MTSR
Metsera
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
MTSR Profile
Metsera, Inc.
A clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulating hormones
3 World Trade Center, 175 Greenwich Street, New York, New York 10007
--
Metsera, Inc., was originally incorporated under the laws of the State of Delaware on June 29, 2022. The company is a clinical-stage biotechnology company developing next-generation injectable and oral trophic stimulating hormones, or NUSH, analog peptides, for the treatment of obesity, overweight and related diseases.